Investigation of clinical effects of treatment with fine particle inhaled corticosteroids exhalation through the nose
Not Applicable
- Conditions
- Eosinophilic chronic rhinosinusitis with bronchial asthma
- Registration Number
- JPRN-UMIN000018038
- Lead Sponsor
- Kansai Medical University
- Brief Summary
HFA-BDP MDI ETN treatment improved all assessed clinica l endpoints and corticosteroid sensitivity without any deter ioration in pulmonary function. FENO and blood eosinophil number were reduced by HFA-BDP MDI ETN treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Not provided
Exclusion Criteria
1. exacerbation within 4 weeks (eg. infection and asthma attack) 2. concomitant disease currently treated (eg. heart diseases, hematologic disorders, respiratory diseases) 3. pregnant patients 4. possibility of lack of examination security.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SInus CT findings before and after treatment
- Secondary Outcome Measures
Name Time Method